Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

The Israel Land Development Company Ltd. Board/Management Information 2019

Aug 1, 2019

6886_rns_2019-08-01_bb3269dc-bba2-4c48-ab4f-24395994e87b.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5391H

Oil and Gas Development Company Ltd

01 August 2019

No.CS04-08/PSX                                                                                August 01, 2019

The General Manager

Karachi Stock Exchange Limited

Stock Exchange Building

Stock Exchange Road

Karachi

Fax No: 021-32437567
London Stock Exchange Plc.               10 Paternoster Square

London EC4M 7LS

Tel: (44) 020 7334 8907

Subject: CHANGE / APPOINTMENT OF MD/CEO OGDCL

Dear Sir,

In continuation of our letter No. CS04-08/PSX dated July 01, 2019 (enclosed), it is informed that Mr. Zahid Mir has relinquished the charge of MD/CEO of the company on July 31, 2019 and Dr. Naseem Ahmed has assumed the charge of MD/CEO on acting charge basis with immediate effect.

The above information is submitted in compliance with PSX Regulations / Code of Corporate Governance for dissemination amongst your members please.

Yours truly,

(Ahmed Hayat Lak)

Company Secretary

Copy to:

The Commissioner (Enforcement),

Securities & Exchange Commission of Pakistan,

NIC Building,

Islamabad.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5391H_1-2019-8-1.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAPBMPTMBBMMIL